Skip to main content
. 2016 Jul 13;19(4):665–694. doi: 10.1093/europace/euw235

Figure 6.

Figure 6

Indications for therapy of patients with Brugada syndrome. Recommendations with class designations are taken from Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013;10:1932–1963, and Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36:2757–9. Recommendations without class designations are derived from unanimous consensus of the authors. ES = extrastimuli at right ventricular apex; ICD = implantable cardioverter-defibrillator; ILR = implantable loop recorder; NAR = nocturnal agonal respiration; RVOT = right ventricular outflow tract; VF = ventricular fibrillation; VT = ventricular tachycardia.